VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Return
24.65%
This Quarter Return
+4.83%
1 Year Return
+24.65%
3 Year Return
+82.72%
5 Year Return
+113.39%
10 Year Return
–
AUM
$498M
AUM Growth
+$202M
(+68%)
Cap. Flow
+$200M
Cap. Flow
% of AUM
40.07%
Top 10 Holdings %
Top 10 Hldgs %
7.15%
Holding
857
New
312
Increased
243
Reduced
122
Closed
179
Top Buys
| 1 |
Apple
AAPL
|
$5.33M |
| 2 |
Biogen
BIIB
|
$4.31M |
| 3 |
Baidu
BIDU
|
$4.24M |
| 4 |
Bausch Health
BHC
|
$4.14M |
| 5 |
CPN
Calpine Corporation
CPN
|
$2.97M |
Top Sells
| 1 |
Coca-Cola Consolidated
COKE
|
$1.81M |
| 2 |
Keurig Dr Pepper
KDP
|
$1.77M |
| 3 |
Sysco
SYY
|
$1.67M |
| 4 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
$1.6M |
| 5 |
Adeia
ADEA
|
$1.52M |
Sector Composition
| 1 | Technology | 14.35% |
| 2 | Healthcare | 14.26% |
| 3 | Industrials | 12.65% |
| 4 | Financials | 11.07% |
| 5 | Consumer Discretionary | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Ingredion
INGR
$8.21B
| $888K | 0.18% |
11,416
+1,490
| +15% | +$116K |
|
152
Progress Software
PRGS
$1.9B
| $883K | 0.18% |
+32,482
| New | +$883K |
|
153
Gen Digital
GEN
$18.2B
| $882K | 0.18% |
37,749
+2,868
| +8% | +$67K |
|
154
Haemonetics
HAE
$2.61B
| $882K | 0.18% |
+19,639
| New | +$882K |
|
|
CBM
155
DELISTED
Cambrex Corporation
CBM
| $880K | 0.18% |
+22,211
| New | +$880K |
|
156
Sonoco
SON
$4.49B
| $868K | 0.17% |
19,094
+3,237
| +20% | +$147K |
|
157
L3Harris
LHX
$51.1B
| $866K | 0.17% |
10,992
+3,243
| +42% | +$255K |
|
|
ALOG
158
DELISTED
Analogic Corp
ALOG
| $866K | 0.17% |
9,531
+1,979
| +26% | +$180K |
|
|
FRAN
159
DELISTED
Francesca's Holdings Corporation
FRAN
| $864K | 0.17% |
4,044
-69
| -2% | -$14.7K |
|
160
Quest Diagnostics
DGX
$20.1B
| $846K | 0.17% |
11,011
-2,450
| -18% | -$188K |
|
161
Kohl's
KSS
$1.84B
| $843K | 0.17% |
10,776
-1,501
| -12% | -$117K |
|
|
MANT
162
DELISTED
Mantech International Corp
MANT
| $837K | 0.17% |
24,664
+2,523
| +11% | +$85.6K |
|
163
Elevance Health
ELV
$69.4B
| $810K | 0.16% |
5,249
-228
| -4% | -$35.2K |
|
164
McKesson
MCK
$86B
| $801K | 0.16% |
+3,540
| New | +$801K |
|
165
Urban Outfitters
URBN
$6.4B
| $797K | 0.16% |
+17,453
| New | +$797K |
|
166
Graham Holdings Company
GHC
$4.92B
| $795K | 0.16% |
+1,253
| New | +$795K |
|
167
Merck
MRK
$210B
| $792K | 0.16% |
14,442
-9,549
| -40% | -$524K |
|
|
DBD
168
DELISTED
Diebold Nixdorf Incorporated
DBD
| $789K | 0.16% |
+22,263
| New | +$789K |
|
169
Cardinal Health
CAH
$35.7B
| $787K | 0.16% |
8,719
+433
| +5% | +$39.1K |
|
170
EchoStar
SATS
$19.3B
| $787K | 0.16% |
18,786
+5,852
| +45% | +$245K |
|
171
Accenture
ACN
$158B
| $773K | 0.16% |
8,249
-2,706
| -25% | -$254K |
|
172
Labcorp
LH
$22.9B
| $773K | 0.16% |
7,132
-921
| -11% | -$99.8K |
|
173
Unitil
UTL
$820M
| $772K | 0.15% |
+22,197
| New | +$772K |
|
174
Consolidated Edison
ED
$35.3B
| $769K | 0.15% |
12,614
-3,308
| -21% | -$202K |
|
175
Kosmos Energy
KOS
$823M
| $767K | 0.15% |
+96,983
| New | +$767K |
|